Swiss stocks - Factors to watch on May 20

Newron Pharmaceuticals SpA

20/05/2021 05:42

ZURICH/BERLIN, May 20 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
    
    ROCHE  ROG.S 
    An immunotherapy showed for the first time it can help
early-stage lung cancer patients survive longer without their
disease returning, according to data released on Wednesday, a
potential turning point for such drugs to be used before tumours
spread.
    The drug, Tecentriq from Roche, works like other
immunotherapies including Merck's  MRK.N  Keytruda and Opdivo
from Bristol Myers Squibb  BMY.N , helping take the brakes off
the immune system so it can attack tumours.  urn:newsml:reuters.com:*:nL5N2N5522
    
    LONZA  LONN.S 
    The Swiss government said on Wednesday it recruited 75
people including federal and university employees to temporarily
staff facilities at Lonza , which struggled to find personnel to
make ingredients for Moderna's  MRNA.O  COVID-19 vaccine.
 urn:newsml:reuters.com:*:nL2N2N62N2
    
    COMPANY STATEMENTS
    * Supernus Pharmaceuticals  NWRN.S  said it had Received
notice letters from MSN, Optimus and Zenara.  urn:newsml:reuters.com:*:nFWN2N60TL
    
    
    DUFRY  DUFN.S 
    First quarter results due.
    
    
    
    EX-DIVIDEND
    VAT  VACN.S  - 4.5 CHF/shr dividend
    
    ECONOMY
    No major economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))